Mapping the Blockage: Biology and Diagnosis
At a Glance
Acquired tear duct stenosis can be caused by gradual inflammation and scarring or by trauma, medical treatment, inflammatory disease, or a tumor. Doctors use examination, irrigation, Jones dye tests, and selective imaging to locate the blockage and tell structural blockage from poor tear drainage.
When your eyes won’t stop watering, the first task for your doctor is to determine if the drainage pathway is physically blocked or if it is simply not working efficiently. This involves categorizing the type of blockage and performing a series of diagnostic tests to map out your unique anatomy.
Primary vs. Secondary Blockages
Doctors divide acquired tear duct obstructions into two main categories based on what caused them.
Primary Acquired Nasolacrimal Duct Obstruction (PANDO)
PANDO is the most common form [1]. It is considered “primary” because there isn’t one single external event that caused it. Instead, it is a multifactorial process where chronic, low-grade inflammation is associated with fibrosis (scar tissue) that slowly narrows the duct [1][2].
Secondary Acquired Nasolacrimal Duct Obstruction (SANDO)
SANDO occurs when a known external factor or underlying disease causes the blockage [3]. Common causes include:
- Medical Treatments: Radioactive iodine (often used for thyroid conditions), chemotherapy, or radiation therapy to the face [4][3].
- Trauma: Fractures to the bones of the face or nose [3].
- Inflammatory Diseases: Conditions like sarcoidosis or granulomatosis with polyangiitis [3].
- Tumors: While rare, growths in the sinus or tear sac can physically block the duct [5].
Distinguishing between PANDO and SANDO is vital because secondary causes sometimes require different treatments or have different surgical success rates [3].
The Diagnostic “Roadmap”
To find the exact location of a blockage, your doctor will perform a physical workup alongside specific tests.
Probing and Irrigation
The most common test is lacrimal irrigation [6]. The doctor places a tiny, blunt tube into the opening of the tear duct (the punctum) and gently flushes it with saline.
- The “Hard Stop”: This generally means the probe has successfully passed through the smaller upper tubes (the canaliculus) and contacted the medial wall of the lacrimal sac. It suggests the upper tubes are open [7].
- The “Soft Stop”: If the probe hits spongy tissue and cannot reach the sac wall, the blockage is likely higher up, in the smaller tubes called the canaliculi [7].
- Reflux: If the saline washes back out of the same hole or the hole next to it, the duct is obstructed [8].
Jones Dye Tests
These tests use a special yellow dye (fluorescein) to see how well your eyes drain naturally.
- Jones I: The doctor puts dye in your eye and waits a few minutes. If they can find the dye in your nose (usually by having you blow into a tissue), the test is positive, meaning the drain is open [9].
- Jones II: If the first test is negative, the doctor will flush the eye with saline. If the yellow dye appears in your nose during the flush, it suggests the system is physically open but functioning poorly [6].
Note: Jones tests have limited sensitivity and are interpreted as adjunctive clues alongside examination and irrigation; a negative Jones I does not perfectly establish whether a blockage is structural or functional.
Structural vs. Functional Blockage
A major goal of diagnosis is telling the difference between a structural blockage and a functional delay.
- Structural Blockage: There is a physical barrier of scar tissue or bone blocking the flow. Irrigation will usually fail [10].
- Functional Delay: The pathway is physically open (irrigation passes easily), but the tears aren’t moving. This can happen if the “tear pump”—the muscles that squeeze the tear sac when you blink—is weak [10][11].
Advanced Imaging: Seeing the Invisible
Advanced imaging is selected for particular clinical questions, trauma, suspected secondary disease, or unclear anatomy, and is not required for every routine patient:
- Dacryocystography (DCG): A specialized X-ray where a contrast dye is injected into the tear ducts to highlight the exact shape and location of a blockage [12].
- CT-DCG: Combines the dye test with a CT scan. This is excellent for seeing the bones and sinuses, especially if you’ve had a facial injury [13].
- MR-DCG: Uses an MRI to see the soft tissues and fluid, though protocols vary and are not routinely real-time dynamic studies [7][14].
- Dacryoscintigraphy (DSG): Uses a tiny amount of radioactive tracer to track how fast tears move through the system, which can provide useful transit information [15][16].
- Nasal Endoscopy: A tiny camera is placed in the nose to see if a polyp, a deviated septum, or a sinus issue is pressing on the tear duct from the outside [6][17].
Common questions in this guide
How are primary and secondary acquired tear duct obstructions different?
What does a hard stop versus a soft stop mean during tear duct irrigation?
What does it mean if saline comes back out during a tear duct test?
Can a negative Jones I test tell whether my blockage is structural?
How do doctors distinguish a physical blockage from a functional tear-drainage problem?
When is advanced imaging used for an acquired tear duct blockage?
Get notified when new evidence is published on acquired tear duct stenosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
Ali MJ
Progress in retinal and eye research 2023; (96()):101193 doi:10.1016/j.preteyeres.2023.101193.
PMID: 37394093 - 2
Etiopathogenesis of Primary Acquired Nasolacrimal Duct Obstruction: What We Know and What We Need to Know.
Ali MJ, Paulsen F
Ophthalmic plastic and reconstructive surgery 2019; (35(5)):426-433 doi:10.1097/IOP.0000000000001310.
PMID: 30730434 - 3
Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
Sweeney AR, Davis GE, Chang SH, Amadi AJ
Ophthalmic plastic and reconstructive surgery 2018; (34(1)):20-25 doi:10.1097/IOP.0000000000000841.
PMID: 27997463 - 4
Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know.
Ali MJ
Ophthalmic plastic and reconstructive surgery 2016; (32(4)):243-8 doi:10.1097/IOP.0000000000000647.
PMID: 26866333 - 5
Lacrimal Sac and Nasolacrimal Duct Tumors Mimicking Chronic Inflammation: A Systematic Review.
Anglitoiu AE, Marin KC, Bratosin F, et al.
Medicina (Kaunas, Lithuania) 2026; (62(1)) doi:10.3390/medicina62010142.
PMID: 41597429 - 6
Dacryocystorhinostomy: Evolution of endoscopic techniques after 498 cases.
Trimarchi M, Giordano Resti A, Vinciguerra A, et al.
European journal of ophthalmology 2020; (30(5)):998-1003 doi:10.1177/1120672119854582.
PMID: 31177827 - 7
Non-contrast MR dacryocystography for the evaluation of epiphora and recurrent dacryocystitis: A preliminary study.
Cè M, Grimaldi E, Toto-Brocchi M, et al.
The neuroradiology journal 2023; (36(4)):397-403 doi:10.1177/19714009221140484.
PMID: 36404757 - 8
Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
Makselis A, Petroska D, Kadziauskiene A, et al.
BMC ophthalmology 2022; (22(1)):12 doi:10.1186/s12886-021-02185-x.
PMID: 34986808 - 9
Evaluating the Endoscopic Jones Primary Dye Test in Lacrimal Dysfunction.
Macri CZ, Tong JY, Almater AI, Selva D
Seminars in ophthalmology 2026; (41(6)):725-728 doi:10.1080/08820538.2025.2588716.
PMID: 41247067 - 10
The role of intubation and dacryocystorhinostomy in the management of functional nasolacrimal duct obstruction: a systematic review.
Ang T, Muthineni V, Almater A, Selva D
International ophthalmology 2026; (46(1)).
PMID: 41770463 - 11
Evaluation of lacrimal drainage system in Pseudoexfoliation syndrome.
Eroglu FC, Sekeroglu MA, Ceran TH, et al.
Eye (London, England) 2022; (36(11)):2094-2098 doi:10.1038/s41433-021-01799-1.
PMID: 34645960 - 12
Dacryocystography: From theory to current practice.
Singh S, Ali MJ, Paulsen F
Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 2019; (224()):33-40 doi:10.1016/j.aanat.2019.03.009.
PMID: 30954539 - 13
Computed Tomography Versus Dacryocystography for the Evaluation of the Nasolacrimal Duct-A Study With 72 Patients.
Papathanassiou S, Koch T, Suhling MC, et al.
Laryngoscope investigative otolaryngology 2019; (4(4)):393-398 doi:10.1002/lio2.293.
PMID: 31453347 - 14
MR dacryocystography: comparison with dacryoendoscopy in positional diagnosis of nasolacrimal duct obstruction.
Higashi H, Tamada T, Mizukawa K, Ito K
La Radiologia medica 2016; (121(7)):580-7 doi:10.1007/s11547-016-0632-7.
PMID: 27048401 - 15
Clinical utility of SPECT/CT and CT-dacryocystography-enhanced dacryoscintigraphy in the imaging of lacrimal drainage system obstruction.
Barna S, Garai I, Kukuts K, et al.
Annals of nuclear medicine 2019; (33(10)):746-754 doi:10.1007/s12149-019-01385-2.
PMID: 31313247 - 16
Outcomes of intubation and endoscopic DCR in functional nasolacrimal duct obstruction.
Shapira Y, Macri C, Usmani E, et al.
Rhinology 2022; (60(4)):308-312 doi:10.4193/Rhin22.047.
PMID: 35475433 - 17
Evaluating failed dacryocystorhinostomy using computed tomography dacryocystography: a preliminary analysis of bony ostium characteristics in an Asian population.
Cui X, Shan K, Wang X, Wang Y
Quantitative imaging in medicine and surgery 2025; (15(3)):2183-2192 doi:10.21037/qims-24-1979.
PMID: 40160634
This page explains how clinicians classify and test acquired tear duct blockages for informational purposes only and does not constitute medical advice. Your eye-care specialist should interpret your examination and test results and recommend care for your situation.